Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06550791 · ClinicalTrials.gov registry record · NA
Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors
A NA study of Neoplasm, Uterine, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT06550791 is a NA study of Neoplasm, Uterine that has completed, run by University of Virginia. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06550791, a NA study of Neoplasm, Uterine, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to promote positive lifestyle change among endometrial cancer survivors by using a group-based intervention. Endometrial cancer survivors are at an increased risk of other health conditions like heart disease, diabetes, and other cancers. The study team at the University of Virginia wants to explore new ways to lower these risks. This study will be evaluating the Anticancer Lifestyle program, which takes a more holistic approach and uses web-based learning modules along with weekly group sessions to discuss each topic of the web-based learning modules.
Conditions Studied
Interventions
- BEHAVIORAL Anticancer Learning Circle
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2025-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06550791
The ClinicalTrials.gov registry entry for NCT06550791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasm, Uterine appearing as the primary indexed condition, and to 1 intervention - of which Anticancer Learning Circle is the first listed.
NCT06550791 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06550791 about?
NCT06550791 is a clinical study titled "Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors". The purpose of this study is to promote positive lifestyle change among endometrial cancer survivors by using a group-based intervention. Endometrial cancer survivors are at an increased risk of other health conditions like heart disease, diabetes, and other cancers. The study team at the University...
What is the current status of trial NCT06550791?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-09-04. Estimated completion is 2025-09-28.
What conditions does trial NCT06550791 study?
This clinical trial studies the following conditions: Neoplasm, Uterine.
What interventions are being tested in trial NCT06550791?
The interventions under investigation include: Anticancer Learning Circle (BEHAVIORAL).
Who is sponsoring clinical trial NCT06550791?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06550791 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.